Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing by Nguyen Tran, MT et al.
ARTICLE
Engineering domain-inlaid SaCas9 adenine base
editors with reduced RNA off-targets and increased
on-target DNA editing
Minh Thuan Nguyen Tran 1✉, Mohd Khairul Nizam Mohd Khalid1, Qi Wang1, Jacqueline K. R. Walker1,
Grace E. Lidgerwood2,3, Kimberley L. Dilworth4, Leszek Lisowski 4,5, Alice Pébay 2,3 & Alex W. Hewitt 1,6
Precision genome engineering has dramatically advanced with the development of CRISPR/
Cas base editing systems that include cytosine base editors and adenine base editors (ABEs).
Herein, we compare the editing profile of circularly permuted and domain-inlaid Cas9 base
editors, and find that on-target editing is largely maintained following their intradomain
insertion, but that structural permutation of the ABE can affect differing RNA off-target
events. With this insight, structure-guided design was used to engineer an SaCas9 ABE
variant (microABE I744) that has dramatically improved on-target editing efficiency and a
reduced RNA-off target footprint compared to current N-terminal linked SaCas9 ABE var-
iants. This represents one of the smallest AAV-deliverable Cas9-ABEs available, which has
been optimized for robust on-target activity and RNA-fidelity based upon its stereochemistry.
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Cytosine base editors (CBEs) direct cytosine-to-thyminechemistry at a user-defined guide sequence (sgRNA)1,2,and comprise a cytosine deaminase derived from verte-
brate (APOBEC and activation-induced deaminase variants)3 or
invertebrate systems (pmCDA1; Target-AID)2. Current genera-
tion adenine base editors (ABEs) employ a dimerized, codon
optimized variant of laboratory-evolved ecTadA (ABEmax)4,5,
and have directed site-specific adenine-to-guanine nucleotide
conversions in a diverse array of systems6,7. Despite their broad
scope for robust on-target editing, non-engineered ABEs have a
significant off-target footprint on the transcriptome and effect
incidences of missense and nonsense mutations8.
Efforts to minimize the occurrence of promiscuous editing
have largely improved the fidelity of existing ABEs by installing
various inactivating mutations in the wild-type domain of the
ecTadA monomer9, or use truncated variants of ABEmax with
amino acid substitution to reduce non-specific contacts with RNA
in the recently described, miniABEmax, which consists of a sin-
gle, evolved ecTadA monomer10,11. To date, these strategies are
effective at improving the biosafety of ABEs but represent a Cas9-
independent solution toward minimizing aberrant editing.
Recently, Huang and colleagues described circularly permuted
base editors in Streptococcus pyogenes Cas9 (SpCas9) and found
that they had comparable on-target activity compared to their
uncircularized counterparts12. Similarly, efforts to engineer a
domain-inlaid variant of base editors in SpCas9 have been
reported, though this has been less well investigated in terms of
their perturbative effects on protein secondary structure and base-
editing profile13.
Here, using insight gained from the profiling of domain-inlaid
and circularly permutant SpCas9 base editors, we show that the
aberrant RNA off-target effects of ABEs can be modulated based
on their overall secondary structure and spatial relation to Sta-
phylococcus aureus Cas9 (SaCas9). Our results establish an
alternative means for increasing on-target DNA-editing effi-
ciencies while minimizing collateral base editing of RNA tran-
scripts, without introducing amino acid substitutions in the base
editor domain. By fine-tuning the spatial positioning between the
base editor and Cas9 component, this work represents a useful
addendum to efforts enhancing base editing activity and fidelity.
Results
Comparison of intradomain and circularly permuted SpCas9-
CBE. The compact size and distinctive cytosine-to-guanine base-
editing signature of the hAIDx deaminase (P182X, with 182
residues) made it an ideal candidate for a functional screen of
intradomain and circularly permuted base editors (Fig. 1a). First,
we selected several sites of interest in the REC2, REC1, and RuvC-
III domains of SpCas9 (Supplementary Fig. 1), which were pre-
viously shown to be highly amenable to protein-domain insertion
without loss of function14. Ordinarily, the hAIDx domain is
tethered to its C-terminal nickase SpCas9 (nSpCas9) via an N-
terminal linker15; therefore, we conserved its previously char-
acterized 44-amino acid N-terminal linker and appended a floppy
glycine–serine-rich linker to its C-terminus to bridge the nSpCas9
and hAIDx protein domains as a domain-inlaid CBE. To broadly
survey the effects of protein-domain alterations on base-editing
activity, we also compared three circularly permuted nSpCas9
constructs of interest (Fig. 1b)16. Circular permutant variants of
the hAIDx base editor at nSpCas9 residues 1010, 1029, and 1058
(Supplementary Fig. 1) were selected for a direct comparison of
on-target editing using a cell line expressing yellow fluorescent
protein (YFP), which has no homologous analog in the human
genome. Collectively, we show that the intradomain insertion of
the hAIDx deaminase maintains a consistent on-target DNA
signature (characterized by cytosine-to-guanine transversions at
position 9 of the sgRNA) compared to its C-terminal variant, and
that nSpCas9 domain-interruptions are most amenable at residue
1058 in our preliminary screen (Fig. 1b; Supplementary Figs. 2
and 3). Comparably, the highest on-target editing was observed
with the circular permutation of nSpCas9 at residue 1029 com-
pared to other circular permutant variants of hAIDx (Fig. 1b).
We also found that the intradomain insertion of rAPOBEC1
(BE3) at residue 1058 maintains on-target cytosine-to-thymine
activity despite a 2.2-fold average reduction in editing efficiency at
the YFP locus (26.9% and 12.1%, respectively). Interestingly,
although the C-terminal appendage of a uracil DNA glycosylase
inhibitor (UGI) directs product fate toward a cytosine-to-thymine
base transition, our head-to-head comparison of CBEs showed
that BE3 had the poorest product purity for a construct bearing a
UGI (Supplementary Figs. 3 and 4). Altogether these results
establish that the inlaying of CBEs at residue 1058 is amenable for
the insertion of different varieties of base editors and is
sufficiently plastic for dramatic structural variations without
deleterious effects (Supplementary Fig. 5).
Circular permutation and intradomain insertion of SpCas9-
ABE variants dramatically affect on-target DNA and off-target
RNA editing. We then generated several conformational variants
of ABEmax to profile their on-target DNA and off-target RNA
editing efficiencies (Fig. 2a). Initially, we adapted our circularly
permuted nSpCas9 designs, which used hAIDx and rAPOBEC1
insertions at position 1029, to an N-terminal, C-terminal, and a
decoupled ecTadA dimer variant of ABEmax. On average, the N-
terminal circular permutant of ABEmax (ABEmax hereafter
referred to as “wildtype”) severely impeded editing at the YFP
locus compared to its wild-type counterpart (4.2% vs. 40.5%,
averaged across three independent technical replicates; Fig. 2b).
However, there was a modest, fourfold improvement in editing
efficiency at a previously well-characterized locus (ABE site 16;
ABE16)5, compared to the YFP locus. Intriguingly, the C-terminal
circular permutant construct had a ten- and fourfold reduction to
on-target editing at the YFP and ABE16 loci, respectively, but
increased the incidence of localized, RNA off-target events at two
promiscuous transcripts (Supplementary Figs. 6 and 7).
Next, we decoupled the ecTadA dimer of ABEmax (Fig. 2a).
Although recent literature has suggested that the unevolved
ecTadA monomer was dispensable to on-target DNA editing11,17,
we decided to further investigate whether decoupling of the
ecTadA monomers influences the on-target editing efficiency of
circularly permuted ABEs. Here, we placed the unevolved ecTadA
monomer of ABEmax at the C-terminus of the circularly
permuted nSpCas9 construct and shifted its evolved monomer
to its N-terminus. As expected, decoupling of ABEmax did not
significantly affect the on-target activity of the N-terminal circular
permutant of ABEmax (Fig. 2b). Surprisingly, however, we found
that there was a modest increase in the incidence of localized
RNA off-target events at the DNAJB transcript, which was
previously observed only by circularly permutating ABEmax at its
C-terminus (Fig. 2c, Supplementary Tables 3–6; Supplementary
Figs. 6 and 7).
Circularly permuted miniABEmax (V82G) was then investi-
gated. MiniABEmax (V82G) has less RNA off-target activity as it
harbors only a single evolved ecTadA monomer and has been
engineered for reduced non-specific RNA contact10. Circular
permutation of the miniABEmax, however, showed no appreci-
able on-target DNA editing and had no significant bearing on the
incidence of off-target RNA events.
Next, we compared the effects of inlaying both the ABEmax and
miniABEmax (V82G) variants at our previously characterized
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intradomain site at residue 1058 in nSpCas9 (Fig. 1a). Overall, we
found a 3.5- and 1.7-fold average reduction to on-target editing at
the YFP and ABE16 loci, respectively, upon intradomain insertion
of ABEmax in nSpCas9 (Supplementary Figs. 8 and 9). Counter-
intuitively however, we also noted that this permutation resulted
in a marked increase in the incidence of RNA off-target events at
the DNAJB transcript compared to its wild-type counterpart, but
reduced off-target events at the SCAP transcript (Fig. 2c;
Supplementary Figs. 6 and 7). For the miniABEmax (V82G)
variant, on-target DNA editing was dramatically abrogated when
the evolved ecTadA monomer was inlaid compared to its native
conformation, but no appreciable difference to the RNA editing
profile was observed (15.5- and 8.5-fold average reductions for
ABE16 and YFP loci, respectively). Altogether, these findings
suggest that both the DNA and RNA activity profiles of ABEs can
be altered based upon their domain positioning in nSpCas9.
Domain engineering of a minimal ABE fine-tunes base-editing
activity based on protein secondary structure. Given these
findings we then designed SaCas9 nickase (nSaCas9)-intradomain
ABE constructs. Although the alignment between SaCas9 and
SpCas9 crystal structures revealed poor structural homology
between the two proteins18,19, we found that residue 1058 in
SpCas9 was conformationally analogous to the poorly crystalized
protein loop of residue 745 in SaCas9. Encouraged by these
insights, we assayed the length of the uncharacterized protein
loop between residues 730 and 745 within the constraints of the
adjacent alpha helices by inserting a base-editing domain at each
amino acid position. To further elucidate the apparent positional
dependency of base-editing activity and protein structure, we
further assayed residues 119 to 132 in nSaCas9 (Supplementary
Fig. 10). These residues were positional analogs to the topo-
graphically equivalent residue of 468 in nSpCas9, which we
assayed in our preliminary screen of intradomain CBE insertions
in the REC lobe of nSpCas9 using hAIDx (Supplementary Fig. 1).
We reasoned that the use of the miniABEmax (V82G) variant
(Sa-miniABEmax[V82G]) may act as a superior base-editing
potentiometer for an activity dependent screen given its
comparable on-target efficiency to ABEmax in nSaCas9 (SaABE-
max). Interestingly, the insertion of a base-editing domain
between residues 119 and 132 in nSaCas9 significantly impeded
the on-target activity of the miniABEmax (V82G) (between 0.00
and 5.47% across residues 119–132), whereas on-target activity
was dramatically improved when inserted between residues 730
and 745 of nSaCas9 (between 5.39 and 17.7% across residues
730–745). Moreover, a gradated, topographical “hotspot” was
revealed by shifting the base editor domain from one residue to
another at the assayed positions (Supplementary Fig. 11), until a
local “maximum” was achieved with the highest on-target editing
efficiency being observed at residue I744 (13.6–17.7% across three
independent technical replicates). Here, the insertion of the
miniABEmax (V82G) base editor at residue I744 (hereafter
referred to as “microABE I744”) showed significantly superior
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on-target activity at the ABE16 locus compared to Sa-
miniABEmax (V82G) and SaABEmax (15.96% vs. 1.19% and
1.03%, respectively; Supplementary Fig. 12). Interestingly, the
insertion of the hAIDx domain in nSaCas9 was also consistent
with the higher on-target editing efficiencies found for the ABEs
for position I744 (microAIDx I744), as compared to G129 and
N730 (Supplementary Fig. 13). However, the insertion of the
hAIDx deaminase at position G129 did not abrogate on-target
editing like it did for the insertion of the miniABEmax (V82G)
domain at this position. Moreover, we noted that on-target
cytosine-to-thymine editing was modestly maintained, albeit with
a slightly altered activity window.
Intradomain insertion can enhance on-target DNA editing and
broaden the activity window breadth. Encouraged by these
preliminary results, we then characterized the activity window of
the microABE I744 against 15 previously validated sites. The
microABE I744 had a broader activity window with improved,
overall on-target editing efficiencies compared to its SaABEmax
and Sa-miniABEmax (V82G) counterparts (Fig. 3a, b). We
observed up to a 2.28- and 1.78-fold increase in editing efficiency
at the A7 position compared to SaABEmax and Sa-miniABEmax
(V82G), respectively. At the A10 position, microABE I744 out-
performed the SaABEmax and Sa-miniABEmax (V82G) by up to
3.63- and 3.09-fold, respectively. Overall, the microABE I744
vastly augments the editing scope of targettable adenines within a
21-nucleotide spacer, displaying a characteristic bi-lobed activity
window spanning from adenine position 4 to 16 (Fig. 3b).
Intradomain insertion can attenuate the incidence of aberrant
off-target RNA editing. We sought to then characterize the
effects of nSaCas9 intradomain base editor insertion on RNA
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activity. Here, we reasoned that the inlaying of a base editor
domain could further attenuate the incidence of RNA off-target
events by exerting either a steric limitation on the deaminase
domain, or by altering the secondary structural folding and
expression of the base editor. In addition to assaying the micro-
ABE I744, the intradomain insertion of miniABEmax (V82G)
base editors at residues G129 (Sa-ID129 miniABEmax (V82G))
and N730 (Sa-ID730 miniABEmax (V82G)) were also challenged
against an adenine-rich RNF2 locus, a previously validated
sgRNA against ABE16, and a non-targeting sgRNA against LacZ.
Here, the microABE I744 reduced the breadth of off-target events
for at least three of the six commonly deaminated RNA off-target
transcripts compared to the Sa-miniABEmax (V82G) and SaA-
BEmax (Fig. 3c; Supplementary Table 3). Strikingly, the micro-
ABE I744 also had a significantly reduced, local RNA off-target
profile compared to its counterparts at residues G129 and N730
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by up to 2- and 1.8-fold, respectively. Interestingly however, ABE
insertion at residue G129 dramatically increased the incidence of
RNA off-target events even relative to the Sa-miniABEmax
(V82G) (Fig. 3c; Supplementary Figs. 14 and 15). Next, we
wanted to determine if whether these differences in RNA off-
target effects were due to variations in protein expression or
protein folding of the domain-inlaid base editors10. We per-
formed western blots with primary antibodies targeting the N-
terminus of domain-inlaid nSaCas9 base editors and the C-
terminal flag tag of the respective constructs. Overall, there was
no major difference in the expected banding patterns for each
construct. Taken together, these results indicate that it was
unlikely that RNA off-target-specific differences were attributable
to protein folding specific variations, such as premature stop
codons occurring within the open reading frame (Fig. 3d; Sup-
plementary Fig. 16).
Finally, RNA-seq was used to characterize the molecular
footprint of the microABE I744, SaABEmax, and Sa-
miniABEmax (V82G) on the transcriptome. The microABE
I744 dramatically lowered the incidence of aberrant mRNA off-
target events compared to both the SaABEmax and Sa-
miniABEmax (V82G) (2243 reads containing adenosine-to-
inosine editing for microABE I744 as compared to 4425 and
52,030 reads for Sa-miniABEmax [V82G] and SaABEmax,
respectively). In some instances, the domain-inlaid base editor
resulted in a sixfold reduction in the number of mRNA off-target
edits (Supplementary Fig. 17) as compared to its non-inlaid
permutant (Sa-miniABEmax (V82G)) (81 vs. 544 reads contain-
ing A-to-I editing, respectively, for transcripts mapped to
chromosome 19). Here, we postulate that the altered positioning
of the deaminating catalytic pocket is “hidden” from the
circulating RNA transcripts, though we cannot definitively
preclude other mechanisms that would affect the RNA muta-
genicity of domain-inlaid ABEs without crystallographic
structures.
To assay whether domain-inlaid ABEs adversely affected their
DNA-editing fidelity, we selected the top 28 predicted gDNA off-
target sites based on the sgRNA-target homology20 of the top
three edited sites (ABE site 11, ABE11; ABE site 8, ABE8; ABE site
1, ABE1). We found that, overall, there was no apparent change in
the off-target DNA-editing breadth of the microABE I744 as
compared to its existing counterparts at putative off-target sites
(Supplementary Data 1). Whole-exome sequencing was further
performed at a depth of 1000× for a less biased measure of DNA-
editing fidelity. In support with previous results, we found that
the off-target DNA fidelity of the microABE I744 did not change
relative to SaABEmax or Sa-miniABEmax (V82G) (between 13
and 26 A-to-G conversions relative to normalized control
samples; n= 3).
Domain-inlaid ABEs enables correction of disease-specific loci
and single-vector AAV-mediated delivery. We then directed the
microABE I744 to correct the highly penetrant PCDH15 Arg245Ter
variant, which causes type 1 Usher syndrome, whereby homo-
zygous carriers have congenital deafness and develop retinitis pig-
mentosa21. We observed a 10-fold increase in editing efficiency and
dramatically lower mRNA off-target effects as compared to Sa-
miniABEmax (V82G) (“Methods”; Supplementary Table 5). As
expected, on-target editing was abrogated upon introduction of the
SaKKH-related mutations, which imposes an incompatible pre-
ference for a canonical thymine at position 6 at the NNGRRN PAM
of our sgRNA targeting the PCDH15 Arg245Ter variant (Supple-
mentary Figs. 18 and 19).
Finally, we sought to demonstrate that the microABE I744 can
be packaged as an all-in-one vector for adeno-associated viral
(AAV) delivery22. Current generation AAV-mediated delivery
platforms for base editors employ a dual-vector system, which is
largely reliant on the use of intein trans-splicing for the
reconstitution of full-length CBE or ABE23. This can hamper
on-target editing efficiencies due to the need for co-delivery and
co-transduction of the payload. As proof-in-principle, we targeted
the previously well-characterized locus, ABE11, and show that our
all-in-one vector can be packaged as AAV-7m8 and AAV-DJ
serotypes. To fit within the packaging constraints of the AAV
vector, we package the minimal SCP1 promoter to drive
microABE I744 expression24, a single mammalian terminator
(bgH polyA), and a hU6 promoter with sgRNA targeting ABE11
or non-targeting LacZ. Next, we adapted the single-stranded
DNA virus sequencing platform and show that no apparent
truncation of the virus has occurred at either the 5′ or 3′ inverted
tandem repeats (ITRs), and that genomic rearrangement events
were few (Fig. 4a, b)25. With this insight, we transduced
HEK293A-YFP cells and observed an editing efficiency of
~0.24% with no selection or enrichment after only three days
of culturing with either the 7m8 and DJ capsid derivatives
(Fig. 4c). Similarly, when the 7m8 and DJ AAV-serotypes were
applied to terminally differentiated iPSC-derived retinal optic
cups at a modest viral titer, we found that the AAV-7m8 serotype
induced editing of the organoids after only 7 days of non-selective
culturing (Supplementary Fig. 20).
Discussion
Overall, the activity profile of the ABEs can be improved for their
on-target efficiency and precision by manipulating the structure
of Cas9. Although previous research has characterized the effects
of protein engineering on the ABE9,10,12,26, our work further
expands upon these efforts by refining the spatial arrangement
between the endonuclease and base editor components. We
show that the same variant of ABE can have different DNA
and RNA editing profiles arising from alterations to their sec-
ondary structure. Through the strategic use of circular permu-
tation and protein-domain insertion, we observe that both the
DNA and RNA footprint can be calibrated based upon a model of
“best-fit.”
We found that the adaptation of ABEmax in nSaCas9 had
significantly lower on-target editing activity compared to its
nSpCas9 counterpart, possibly due to protein-specific differences
between SaCas9 and SpCas917. Likewise, the use of the recently
described miniABEmax variant in nSpCas9 showed robust on-
target editing in its native, N-terminal conformation, but failed to
show appreciable editing in the same permutation in nSaCas9.
Interestingly, however, on-target efficiency was entirely abrogated
when miniABEmax was inserted as an intradomain construct in
nSpCas9, but conversely was enhanced upon its insertion at its
positional analog in nSaCas9. Although the development of the
miniABEmax suggests that off-target activity can be inherently
minimized as a Cas9-independent solution through amino acid
substitutions and deletions, we show that these effects appear to
be particular to a specific, overall secondary structure.
In contrast to the vastly superior on-target and reduced off-
target capabilities of the microABE I744, the intradomain min-
iABEmax variant at residue G129 showed a counterintuitive
increase in the incidence of RNA off-target events and an overall
reduction to on-target editing efficiency. These effects were not
due to obvious differences in protein expression or protein
folding (Fig. 3d). Taken together, we believe that inlaid base
editors may sterically hinder the stochastic movement of the
deaminase domain from freely circulating RNA transcripts,
though it is impossible to make such an assertion without further
crystallographic structures.
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When the microABE I744 was packaged into an AAV-
deliverable format, we found somewhat modest editing in both
dividing and non-dividing cell types. Deep sequencing of the
AAV-packaged viral genomes revealed that editing efficiency was
not affected by truncations at the ITRs or due to genomic rear-
rangements. Currently, it is unlikely that the editing efficiency of
our single AAV vector-packaged microABE I744 has surpassed a
therapeutic threshold. Nonetheless, given our promising in vitro
plasmid-based results, future directions could consider further
optimization to the AAV payload architecture by placing the U6-
sgRNA component in the antisense direction, or adding addi-
tional regulatory elements for enhanced protein expression, as
well as comparing our single-vector format against dual-vector
constructs such as packaged SaABEmax or through the screening
of different promoter sequences23.
In summary, we show that the manipulation of the
Cas9 secondary structure can further augment the precision of
ABEs by carefully considering the broader, steric relationship
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Fig. 4 AAV-mediated delivery of a single construct containing domain-inlaid nSaCas9 I744 (microABE I744) and a sgRNA targeting either ABE site 11
or LacZ. a Schematic showing the all-in-one AAV construct driving the expression of the microABE I744 via an SCP1 minimal promoter and a hU6
promoter for the sgRNA component, with example aligned reads from 7m8-AAV vector and its corresponding plasmid, as well as (b) AAV-DJ packaged
vector and its corresponding plasmid. c Percentage of A-to-G conversions are presented as an average of three technical replicates, for either the AAV-
7m8 or AAV-DJ serotypes, in HEK293A-YFP cells. Source data are available in the Source data file.
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between Cas9 and base editors. At only 3.8 kb in size, it is small
enough to fit within the constraints of an AAV vector with
adequate packaging space for a promoter and its cognate guide
sequence. In addition, the broad editing window of the microABE
I744 and its robust on-target editing and reduced RNA signature
on the transcriptome makes it an ideal candidate for further
preclinical testing.
Methods
PyMOL analysis and I-TASSER alignment of SpCas9 and SaCas9. Crystal
structures of S. pyogenes Cas9 (PDB accession 4OO8) and S. aureus Cas9 (PDB
accession 5CZZ) were downloaded from the Protein Data Bank and visualized
using PyMOL v2.3.127. Given that residues 731–741 in SaCas9 were not crystalised,
I-TASSER was used to generate a predictive crystal structure (available upon
request) that was then superimposed with that of S. pyogenes Cas9 using the
“super” command in PyMOL28. The “complete” SaCas9 structure was then aligned
structurally using the TM-Align webtool from I-TASSER to determine the struc-
tural homology between the two proteins28.
Plasmid construction and cloning. Plasmids were generated and Sanger sequence
verified by Genscript (Piscataway) (Supplementary Table 1). Plasmids expressing
the U6-sgRNA scaffold with mCherry fluorophore reporter were cloned into either
the pX552-CMV-mCherry-U6-SpCas9_sgRNA scaffold (Addgene #107051) or
PX552-CMV-mCherry-U6-SaCas9_sgRNA scaffold (Addgene #107053) via SapI
(NEB) digest sites using oligonucleotides corresponding to the target spacer
(Supplementary Table 2; Supplementary Data 2).
AAV packaging and single-stranded virus sequencing. The AAV constructs
were packaged into Recombinant recombinant AAV (rAAV) vectors particles were
produced using a standard transient transfection HEK293 cells29. Briefly, HEK293
cells were triple transfected using PEI (Polysciences Cat#239662) with pAd5 helper
plasmid29,30, pAAV transfer vector and AAV-helper plasmid encoding rep2 and
the capsid of interest (packaging using pX551, and pseudo-serotyped with the DJ or
7m8) capsid. Viral Packaged vector particles vectors were purified using iodixanol-
based density gradients31, and vector genomes were titred quantified by real-time
quantitative PCR (RT-qPCR) as previously described32. Single-stranded virus
sequencing is described by Lecomte and colleagues25. Briefly, each AAV vector was
treated with DNaseI, Proteinase K, and RNase A. An internal normalizer was
assembled containing each of the DNA species that could be found in the AAV
preparation; adenovirus helper plasmid, rep-cap helper plasmid, the transfer
plasmid containing the vector genome, the transfer plasmid backbone and
HEK293T genomic DNA. All samples then underwent a DNA clean-up step.
Second strand synthesis was performed by hybridizing a random hexanucleotide
mix (random primer 6, cat#1230S NEB) using DNA pol I (cat#M0209S NEB).
Samples then underwent an additional DNA clean-up step followed by library prep
and Illumina MiSeq sequencing.
Cell culture. HEK293A cells (R70507, ThermoFisher Scientific) expressing yellow
fluorescent protein (HEK293A-YFP), which we previously generated33, were cul-
tured in Dulbecco’s modified Eagle medium (DMEM) with high glucose (Life
Technologies). Culture media was supplemented with 10% (vol/vol) Fetal Bovine
Serum (Life Technologies) and 1% (vol/vol) antibiotic-antimycotic (Thermofisher
Scientific). HEK293A-YFP cells were maintained in the aforementioned media at
37 °C with 5% CO2 for cell culture experiments. Cell culture work used HEK293A-
YFP cells that were less than 20 passages old. Cells carrying the full PCDH15 cDNA
sequence with the Arg245ter (NM_033056.4:c.733C>T) variant were generated
using the Flp-In T-Rex core kit on a Flp-In T-Rex cell background (R78007,
Invitrogen, ThermoFisher Scientific) as per manufacturer’s instructions and main-
tained similar to HEK293A lines. H9 human embryonic stem cells (WA09; WiCell)
were differentiated into retinal cup organoids using the protocol described by
Reichman and colleagues34. After terminal differentiation for 30 weeks, optic cups
were chosen for the final AAV experiments. Mycoplasma testing was performed on
a biweekly basis using PCR Mycoplasma Test Kit I/C (Banksia Scientific).
Transfections and DNA/RNA extractions. For on-target DNA and off-target
RNA characterization, HEK293A-YFP cells were seeded at a density of 50,000 cells
per well in a 24-well, tissue culture-treated plate (In Vitro Technologies). Subse-
quently, 8 µL ViaFect Transfection reagent (Promega) with 1 µg CRISPR base
editor plasmid and 1 µg sgRNA-expressing plasmid was transfected into cells
20–24 h after plating. Fresh media containing 20 µg/mL Blasticidine (Sigma-
Aldrich) was exchanged 18–22 h after transfection to select for cells expressing the
base editor construct. Further enrichment was performed 18–22 h following the
first selection round with the replacement of media containing 30 µg/mL Blas-
ticidine. Overall, cells were cultured for strictly no longer than 72 h after initial
transfection before washing with ×1 PBS (ThermFisher Scientific) due to the loss of
RNA A-to-I edits in the transcriptome over time. For the initial on-target gDNA
editing screen of nSaCas9 intradomain constructs however, total culturing time was
5 days to ensure for maximum selection with Blasticidine, and were extracted for
DNA only. For those experiments involving 3 days of culturing, RNA and DNA
were simultaneously harvested using 350 µL Buffer RLT Plus as part of the Allprep
DNA/RNA Mini Kit (QIAGEN) following the manufacturer’s protocol. PCDH15
Arg245Ter Flp-In T-Rex lines were transfected with 1 µg base editor construct and
0.45 µg sgRNA plasmid (FugeneHD™, Promega), and selected with 1 µg/mL pur-
omycin for 5 days. DNA and RNA samples were eluted in 30 µL Buffer EB and
RNase-free water, respectively, with 1.5 µL RNaseOUT Recombinant Ribonuclease
Inhibitor (Life Technologies) added to the eluted RNA sample. For experiments
involving AAV-transduction, HEK293A-YFP cells were plated at a density of
50,000 cells per well, 24 h prior to transduction at a multiplicity-of-infection (MOI)
of 2 × 106 viral genomes/cell. After 72 h of culture, cells were washed twice with
PBS and harvested. Retinal organoids were transduced with 8.0 × 1010 to 1.2 × 1011
viral genomes for 7 days without selection and harvested.
Western blot of domain-inlaid base editors. In a 6-well plate, 200,000
HEK293A-YFP cells were plated 1 day prior and transfected with 2.5 µg of plasmid
DNA expressing domain-inlaid base editors in triplicates as detailed above. Cells
were harvested according to manufacturer’s instructions using RIPA Lysis and
Extraction Buffer (Life Technologies) and Halt™ Protease Inhibitor Cocktail (1X)
(Life Technologies) after 72 h of culturing as detailed above. Lysate concentrations
were normalized using the Pierce™ BCA Protein Assay Kit (Life Technologies)
according to manufacturer’s instructions, and 40 µg of reduced protein was loaded
into each gel (Bolt™Mini Gels; Life Technologies) and ran for 1 h at 130 V. Transfer
was performed using the iBlot™ 2 System (Life Technologies) using the following
settings: 20 V for 1 min, 23 V for 8 min, 25 V for 4 min. Blocking was performed at
room temperature for 1 h with blocking buffer: 5% skim milk (Woolworth, #2885)
in 1X TBST (20 mM Tris, 150 mM NaCl, 0.5% Tween 20, pH 7.6). All subsequent
washes were performed in triplicates using 1X TBST for 5 min at a time. Mem-
branes were then incubated in primary antibodies diluted in 1X TBST at 4 °C with
gentle agitation overnight. For western blot experiments involving HRP-conjugated
primary antibodies against the N-terminus of domain-inlaid base editors, a 1:4000
dilution ratio was used (S. aureus CRISPR/Cas9 antibody; C15200230-100, Custom
Sciences). For those experiments involving the C-terminus of domain-inlaid base
editors, a 1:750 dilution ratio was used (DYKDDDDK Tag monoclonal antibody
MA1-91878, Life Technologies). Histone H3 was used as a loading control for all
experiments and diluted in a 1:4000 ratio (H3pan Antibody 1B1B2, C15200011,
Custom Sciences). Following a washing step, the membranes were incubated in a
secondary antibody diluted in a 1:4000 ratio in 1X TBST (goat anti-mouse IgG (H
+ L) secondary antibody, HRP, 31430, Life Technologies) for 1 h at room tem-
perature with gentle agitation. Membranes were washed again and incubated with
chemiluminescence buffer (SuperSignal™ West Pico PLUS Chemiluminescent
Substrate, 34577, Life Technologies) on a transparent film according to manu-
facturer’s instructions and imaged using the Amersham™ Imager 600. Densito-
metry analysis was performed using the in-built function with default and “high
sensitivity” settings to derive chemiluminescent intensity of the protein bands.
Relative chemiluminescent intensity to the loading control was calculated by
dividing the intensity for the protein band-of-interest by the signal for the loading
control for each well on the same image.
RNA reverse transcription and targeted PCR amplification. Between 200 and
400 ng of RNA was reverse transcribed using the High-Capacity RNA-to-cDNA™
Kit (Life Technologies) following the manufacturer’s instructions. RNA samples
were paired with their counterpart gDNA samples for targeted amplification. The
cDNA samples were diluted 1:10 and 2 µL of the diluted cDNA was used as input
for the first-round PCR amplification of either RNA off-target sites or undiluted
gDNA for those experiments involving DNA on-target sites (Supplementary
Table 2). Briefly, PCR reactions were made up to 25 µL comprising 12.5 µL Q5 Hot
Start High-Fidelity 2X Master Mix (NEB), 1.25 µL of forward and reverse primers
containing 5′ flanking illumina style adapter overhangs, and diluted cDNA or
50–100 ng of gDNA under thermocycling conditions of 98 °C initial denaturation
for 30 s, and 30 cycles of 98 °C denaturation for 10 s, 65 °C annealing for 30 s, and
72 °C extension for 12 s with a 72 °C final extension for 2 m. PCR amplification was
validated using electrophoresis using 1.5% agarose gel and cleaned using Agencourt
AMPure XP (Beckman Coulter) 1.8X paramagnetic bead cleanup.
RNA-seq analysis. Sequencing libraries were prepared using NEBNext(R)
UltraTM RNA Library Prep Kit for Illumina(R) and sequencing was carried out on
HiSeq X Ten using a 2×150-bp paired-end configuration at Genewiz (Suzhou,
China). Libraries were downsampled to 120 million reads using seqtk v.1.3 (r106)
(https://github.com/lh3/seqtk). The downsampled libraries were processed
according to GATK best practices for RNA-seq variant calling10. Briefly, raw
sequencing reads were aligned to the human hg38 reference genome using STAR
(v.2.7.2b). Next, tools from GATK (v.4.1.3.0) that include MarkDuplicates,
SplitNCigarReads, BaseRecalibrator, and ApplyBQSR were used to process the
aligned reads. Known variants in dbSNP build 138 were used for base quality
recalibration. Finally, “analysis-ready” BAM files were subjected to bam-readcount
and HaplotypeCaller to estimate per-library nucleotide abundances per position
and to identify RNA base-editing variants, respectively. Total A-to-I edits per
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library were calculated as the sum of A-I edits on the positive strand and T-C edits
on the negative strand.
Whole-exome sequencing analysis. Whole-exome sequencing was performed on
MGI DNBSEQ-G400 using a 2×150-bp paired-end configuration at Genewiz
(Suzhou, China). A workflow similar to the RNA-seq analysis was used. In brief,
libraries were downsampled to 510 million reads using seqtk v.1.3 (r106) (https://
github.com/lh3/seqtk) and were processed according to GATK best practices. Tools
from GATK (v.4.1.3.0) were used for paired-end alignment, removal of duplicated
reads and base quality recalibration. The “analysis-ready” BAM files were subjected
to the same filtering pipeline as described in RNA-seq analysis. DNA-editing rates
attributed to the base editors were calculated by subtracting the background rates
of A-to-G and T-to-C substitutions in the control sample from the base editor-
treated sample.
Library preparation for targeted amplicon sequencing. Following the first-
round PCR amplification and cleanup of amplicons containing on-target sites or
RNA off-target sites, a second-round barcoding PCR was performed using between
20 and 150 ng of the purified first-round PCR products. The barcoding PCR added
unique dual i5/i7 indices using the Nextera XT index kit V2 (Illumina). Q5 Hot
Start High-Fidelity 2X Master Mix was used following manufacturer’s instructions
for a total volume of 25 μL, with 2.5 μL of i5 and i7 Nextera XT indices added,
followed by thermocycling conditions as described: 95 °C for 2 m, then 15 cycles of
(95 °C for 15 s, 61 °C for 20 s, and 72 °C for 20 s), followed by a final 72 °C
extension of 2 m5. Subsequently, the second-round PCR products were purified
using 0.7× paramagnetic bead cleanup and quantified using Qubit™ dsDNA BR
Assay Kit (Life Technologies). Each sample was then normalized to 4 nM and 5 µL
of each library member was pooled into a final library that was validated using
High Sensitivity D1000 ScreenTape (Agilent Technologies). The final library was
paired-end sequenced (2 × 251) on the Illumina MiSeq machine using 600-cycle
MiSeq Reagent Kit v3.
Amplicon sequencing analysis. Paired-end fastq files were joined and trimmed35,
before being processed using the CRISPResso2 (V.2.0.29) workflow36. For the
specific calculation of off-target RNA A-to-I editing, amplicons were PCR ampli-
fied following reverse transcription and cDNA synthesis as described above, using
the primer set for DNAJB1, MTA2, PTBP2, SAP30BP, LCMT1, and SCAP. In
addition to comparing the editing frequency of the most highly edited adenine
nucleotide position in each amplicon, we summed all A-to-I nucleotide conver-
sions across all relevant sites of each individual amplification. Heatmaps quanti-
fying the off-target profiles were generated in R (v. 1.2.5019) using the “superheat”
package.
Statistical analysis. The average nucleotide modification percentage outputs from
CRISPResso2 (V.2.0.29) were pooled across independent biological and technical
replicates for each nucleotide position in the amplicon. Welch Two-sample t-tests
were performed to compare differences in editing efficiencies, and a p value of
<0.005 was considered statistically significant. As outlined above, specifically, for
comparative analyses of the six RNA off-target transcripts (DNAJB, MTA2, PTBP2,
SAP30BP, LCMT1, and SCAP), both average adenine-to-guanine (inosine) editing
across the length of the amplicon, and also the highest edited position of the
amplicon were considered10. The average of the amplicon was considered as
multiple off-target events were observed relative to the untransfected mock control.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
All raw sequencing reads have been uploaded to the European Nucleotide Archive under
the accessions: PRJEB35675 (MiSeq sequencing); PRJEB38819 (RNA-seq profiling); and
PRJEB38622 (whole-exome sequencing).
Previously determined crystal structures for SpCas9 and SaCas9 are available from the
Protein Data Bank at https://www.rcsb.org/structure/4oo8 and https://www.rcsb.org/
structure/5CZZ, respectively. Any other relevant data are available from the authors
upon reasonable request. Source data are provided with this paper.
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